Legal Representation
Attorney
ROSEMARY S TARLTON
USPTO Deadlines 1 active 1 overdue
| Deadline Type | Event Code | Deadline Date | Days Until | Priority | Extension Available |
|---|---|---|---|---|---|
|
ITU SOU
Notice of Allowance Mailed - SOU Required |
NOAMO | Jul 24, 2006 | 6923 days overdue | High | Until Jan 24, 2007 |
Application History
24 events| Date | Code | Type | Description |
|---|---|---|---|
| Sep 26, 2006 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Sep 26, 2006 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Jan 24, 2006 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Nov 9, 2005 | DOCK | D | ASSIGNED TO EXAMINER |
| Nov 1, 2005 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Oct 12, 2005 | NPUB | O | NOTICE OF PUBLICATION |
| Sep 13, 2005 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Sep 9, 2005 | ALIE | A | ASSIGNED TO LIE |
| Sep 7, 2005 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Sep 6, 2005 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Aug 29, 2005 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Aug 9, 2005 | ALIE | A | ASSIGNED TO LIE |
| Aug 9, 2005 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Jul 25, 2005 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jul 22, 2005 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED |
| Jul 5, 2005 | I | PAPER RECEIVED | |
| Jul 5, 2005 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Feb 7, 2005 | CNRT | F | NON-FINAL ACTION MAILED |
| Feb 4, 2005 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Jan 25, 2005 | DOCK | D | ASSIGNED TO EXAMINER |
| Dec 29, 2004 | ALIE | A | ASSIGNED TO LIE |
| Dec 13, 2004 | I | PAPER RECEIVED | |
| Dec 13, 2004 | DMCC | I | DATA MODIFICATION COMPLETED |
| Jun 28, 2004 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Biological chemical diagnostic test kits for clinical or medical laboratory use, namely, for use in analysis of gene expression, genetics, single nucleotide polymorphism, haplotypes, proteins, and biological samples, for use in detecting diseases, for use in determining the progression of diseases, and for use in determining drug responses; diagnostic medical reagents, chemicals and solid matrix materials for biological, clinical or medical laboratory use for use in diagnosing inflammatory, infectious, central nervous system, cardiovascular, neurological, endocrine, autoimmune and genetic diseases, developmental disorders and cancer
First Use Anywhere:
0
First Use in Commerce:
0
Active Deadlines
Notice of Allowance Mailed - SOU Required
Due: Jul 24, 2006
Overdue
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"REFERENCE LABORATORY"